Immunai
Immunai maps the immune system using single-cell genomics and machine learning.
$215M Series B+ ·
Led by Koch Disruptive Technologies · Source: startupintros.com
Total raised: $295M across 3 sourced rounds
All 3 rounds ↓Signals
About Immunai
It offers an operating system with solutions for target discovery, preclinical evaluation, and clinical trial optimization. Its customers are biopharmaceutical companies and research institutions.
Immunai | 3 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $215M | startupintros.com | ||
| Series A | $60M | startupintros.com | ||
| Seed | $20M | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
NS
Noam Solomon CEO & Co-Founder@NoamSolomon1 · source: immunai.comAS
Ansuman Satpathy Co-FounderLinkedIn · source: foundertrace.comDL
Dan Littman FounderLinkedIn · also Vedanta BiosciencesDW
Danny Wells FounderLF
Luis F Voloch Co-FounderLinkedIn · source: foundertrace.comMJ
Mark Jacobstein Chief Business Officer
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | Date not given | |
| Not disclosed publicly | Date not given |
Investors
88VC
AAlexandria Venture Investments
CCataliolead investor
CCharles and Lynn Schusterman Family Philanthropieslead investor
DDexcel Pharmalead investor
DDuquesne Family Officelead investor
GGefen CapitalIICon
KKoch Disruptive Technologieslead investor
MMeron Capital
PPiedmont Capital Investments
TTalos VCTTLV Partnerslead investor
VViola Grouplead investor
Companies like Immunai
SSingleCell BiotechnologyPre SeedCClaris Bio$118M Series B+ · Jul 2026
AAtrandi Biosciences$25M Series A · Feb 2025
AActio Biosciences$66M Series B+ · Jun 2025
LLightcast$27M Series B+ · Apr 2026
1100XBIOPre Seed · Oct 2026
Other companies backed by Koch Disruptive Technologies
GGatik$200M Series B+ · Aug 2026
HHappyRobot$150M Series B+ · Aug 2026
OOptimal Dynamics$40M Series B+ · Apr 2026
BBlue Current$80M Series B+ · Dec 2025
UUpgrade$165M Series B+ · Oct 2025
AAmplio$11.1M Series A · Sep 2025
Koch Disruptive Technologies portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immunai (get a free API key).